Heath Mackley

Clinical trials

• Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma

  Principal investigator · Withdrawn · Phase 2

  Milton S. Hershey Medical Center

  2009–2011
• Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2025–2032
• De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  Site PI · Recruiting · Phase 3

  NRG Oncology

  2021–2041
• Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  Site PI · Recruiting · Phase 3

  Canadian Cancer Trials Group

  2018–2027